Rachael A Sorg

Characteristics of Real-World Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval.

A. Abernethy, S. Khozin, R. Pazdur, 2018, The oncologist.